Recent developments in epidemiology, treatment, and diagnosis of tuberculosis
Author:
- 1 February 1999
- journal article
- research article
- Published by Springer Nature in Current Infectious Disease Reports
- Vol. 1 (1) , 80-88
Abstract
The resurgence in cases of active tuberculosis in North America in the past decade has prompted increases in funding for tuberculosis treatment, research, and education. As a result, the number of new cases of tuberculosis has declined and cases occur in smaller pockets of well-characterized populations, such as communities of foreign-born persons and socioeconomically disadvantaged groups. New strategies for the treatment of both active and latent tuberculosis may soon include the newly licensed, long-acting rifamycin, rifapentine, but further studies are needed to determine optimal dosing regimens for this agent. Experts in tuberculosis and HIV infection have made headway in defining the optimal therapy for each current therapeutic option, and recently published guidelines are a useful document for clinicians. Rifabutin-based regimens are one approach toward achieving the optimal treatment of both diseases simultaneously. Finally, newly licensed molecular diagnostic tests for direct use on clinical specimens are intriguing, but their clinical utility remains to be defined.Keywords
This publication has 81 references indexed in Scilit:
- Evaluation of an Intensive Intermittent‐Induction Regimen and Duration of Short‐Course Treatment for Human Immunodeficiency Virus–Related Pulmonary TuberculosisClinical Infectious Diseases, 1998
- Variation of Chest Radiographic Patterns in Pulmonary Tuberculosis by Degree of Human Immunodeficiency Virus‐Related ImmunosuppressionClinical Infectious Diseases, 1997
- Isoniazid preventive therapy for tuberculosis in HIV-1-infected adultsAIDS, 1997
- Antimicrobial Activity of RifabutinClinical Infectious Diseases, 1996
- Use of Rifabutin in the Treatment of Pulmonary TuberculosisClinical Infectious Diseases, 1996
- The Effect of Thalidomide on the Pathogenesis of Human Immunodeficiency Virus Type 1 and M. tuberculosis InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 1996
- Two-year follow-up of persons with HIV-1− and HIV-2-associated pulmonary tuberculosis treated with short-course chemotherapy in West AfricaAIDS, 1995
- Transmission of Tuberculosis in New York City -- An Analysis by DNA Fingerprinting and Conventional Epidemiologic MethodsNew England Journal of Medicine, 1994
- The Epidemiology of Tuberculosis in San Francisco -- A Population-Based Study Using Conventional and Molecular MethodsNew England Journal of Medicine, 1994
- Tuberculosis: Commentary on a Reemergent KillerScience, 1992